Nucleoside phosphoramidate prodrugs of 2'-deoxy-2'-fluoro-2'-c-methyluridine
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
27 claims: 2 independent, 25 dependent
- 1217228/3 Claims 1. A compound or its stereoisomer thereof selected from among (S)-2-{[(2R,3R,4R55R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid methyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -3-methyl-butyric acid methyl ester;(S)-2-{(4-bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-3-methyl-butyric acid methyl ester;(S)-2-{(4-bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid methyl ester;(S)-2-{[(2R,3R,4R>5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid ethyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -(naphthalen-1 -yloxy)-phosphorylamino}-propionic acid benzyl ester;{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-acetic acid methyl ester;(S)-2-{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid methyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -(naphthalen-1 -yloxy)-phosphorylamino}-propionic acid methyl ester;(S)-l-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphoryl}-pyrrolidine-2-carboxylic acid methyl ester;(S)-2- {[(2R,3R,4R,5R)-5 -(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid butyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid benzyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid methyl ester;(S)-2 - { (4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5 -(2,4-dioxo-3,4-dihydro-2H- pyrimidin-1 -yl)-4-fluoro-3 -hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] - phosphorylamino}-propionic acid methyl ester;698 217228/3 (S)-2-{(3,4-Dichloro-phenoxy)-[(2R,3R,4R>5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} -propionic acid methyl ester;(S)-2-{[(2R,3R,4R55R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid sec-butyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino}-propionic acid butyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid ethyl ester;(S)-2 - {[(2R,3R,4R,5R)-5 -(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid isopropyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid benzyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino}-propionic acid isopropyl ester;(S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid benzyl ester;(S)-2-{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid butyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -p-tolyloxy-phosphorylamino } -propionic acid isopropyl ester;(S)-2- {[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3 -hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid butyl ester;(S)-2-{(3,4-Dichloro-phenoxy)-[(2R,3R,4Rj5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid ethyl ester;(S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid isopropyl ester;(S)-2-{[(2R,3R,4R>5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino}-propionic acid benzyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3- hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid pentyl ester;699 217228/3 (S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3 -hydroxy-4-methy l-tetrahydro-iuran-2-y lmethoxy] -phosphorylamino}-propionic acid isopropyl ester;(S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid butyl ester;(S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid ethyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-p-tolyloxy-phosphorylamino}-propionic acid butyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo- 3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-p-tolyloxy-phosphorylamino}-propionic acid benzyl ester;(S)-2- {[(2R,3R,4R,5R)-5 -(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid methyl ester;(S)-2- {[(2R,3R,4R,5R)-5 -(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 4-fluoro-benzyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 3-methyl-butyl ester;(S)-2-{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid ethyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid cyclohexyl ester;(S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid butyl ester;(S)-2-{(4-Bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid isopropyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid cyclohexyl ester;(S)-2-{[(2R,3R,4R>5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-bromo-phenoxy)-phosphorylamino} -propionic acid cyclohexyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3- hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid isopropyl ester;700 217228/3 (S)-2-{[(2R,3R,4R>5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid cyclohexyl ester;(S)-2-{[(2R,3R,4R;5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-butyric acid cyclohexyl ester;(S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4 R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-butyric acid isopropyl ester;(S)-2- {[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2,2-difluoro-ethyl ester;(S)-2- {[(2R,3R,4R,5R)-5 -(2,4-Dioxo- 3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2,2,2-trifluoro-l-trifluoromethyl-ethyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid 2-fluoro-1 -fluoromethyl-ethyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo- 3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid cyclopropyl methyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -butyric acid cyclopentyl ester;(S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H -pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-(3,4-dichloro-phenoxy)-phosphorylamino}-propionic acid benzyl ester;and (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-l-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy] -phenoxy-phosphorylamino } -propionic acid 2-fluoro-ethyl ester.
- 4A compound selected from among (S)-methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;(S)-methyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)acetate;methyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)acetate;(S)-isopropyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;(S)-isopropyl 2-(((S)-(4-chlorophenoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)phosphoryl)amino)propanoate;(S)-isopropyl 2-(((R)-(4-chlorophenoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3 -hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)phosphoryl)amino)propanoate;(S)-cyclohexyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;(S)-cyclohexyl 2-(((R)-(((2R,3R,4R>5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;(S)-cyclohexyl 2-(((S)-(((2R,3R,4R>5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(4-fluorophenoxy)phosphoryl)amino)propanoate;and (S)-cyclohexyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(4-fluorophenoxy)phosphoryl)amino)propanoate.
Independent claims2
5 paragraphs in 1 section, as filed
217228/4
NUCLEOSIDE PHOSPHORAMEDATE PRODRUGS WO 2008/121634 PCT/US2008/058183
The present application is a divisional application of Israeli patent application no. 201239 dated March 26, 2008. 10
Field of Invention 15 The present invention pertains to nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals. The invention provides novel chemical 20 compounds, and the use of these compounds alone or in combination with other antiviral agents for treating HCV infection.
Background
Hepatitis C virus (HCV) infection is a major health problem that leads to chronic liver disease, such as cirrhosis and hepatocellular carcinoma, in a
154 members in 37 offices
Priority claims16
| Document | Office | Kind | Date |
|---|---|---|---|
| 90931507 | United States of America | P | |
| 90931507 | United States of America | P | |
| 98230907 | United States of America | P | |
| 98230907 | United States of America | P | |
| 5301508 | United States of America | A | |
| 5301508 | United States of America | A | |
| 2008058183 | United States of America | W | |
| 2008058183 | United States of America | W | |
| 12053015 | – | – | – |
| 60909315 | – | – | – |
| 60982309 | – | – | – |
| PCTUS2008058183 | – | – | – |
| US20070909315P | – | – | – |
| US20070982309P | – | – | – |
| US20080053015 | – | – | – |
| WO2008US58183 | – | – | – |
Members154
| Document | Office | Kind | |
|---|---|---|---|
| AU2008232827A1 | Australia | A1 | |
| CA2682230A1 | Canada | A1 | |
| WO2008121634A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CL2008000902A1 | Chile | A1 | |
| TW200904453A | Taiwan Province of China | A | |
| AR066898A1 | Argentina | A1 | |
| MX2009010401A | Mexico | A | |
| US2010016251A1 | United States of America | A1 | |
| KR20100016041A | Republic of Korea | A | |
| WO2008121634A3 | World Intellectual Property Organization (WIPO) | A3 | |
| IL201239A0 | Israel | A0 | |
| IL201239D0 | Israel | D0 | |
| EP2203462A2 | European Patent Office (EPO) | A2 | |
| JP2010532747A | Japan | A | |
| CN101918425A | China | A | |
| CO6260023A2 | Colombia | A2 | |
| RU2009139968A | Russian Federation | A | |
| US7964580B2 | United States of America | B2 | |
| US2011257122A1 | United States of America | A1 | |
| IL217228A0 | Israel | A0 | |
| IL217228D0 | Israel | D0 | |
| TWI357332B | Taiwan Province of China | B | |
| KR20120034801A | Republic of Korea | A | |
| SG179445A1 | Singapore | A1 | |
| NZ579880A | New Zealand | A | |
| JP2012121903A | Japan | A | |
| AU2008232827B2 | Australia | B2 | |
| AU2012241173A1 | Australia | A1 | |
| MY147409A | Malaysia | A | |
| US8334270B2 | United States of America | B2 | |
| IL222810A0 | Israel | A0 | |
| IL222810D0 | Israel | D0 | |
| US2013029929A1 | United States of America | A1 | |
| IL201239A | Israel | A | |
| RU2478104C2 | Russian Federation | C2 | |
| ZA201200310B | South Africa | B | |
| ZA200906647B | South Africa | B | |
| IL217228AThis record | Israel | A | |
| NZ599206A | New Zealand | A | |
| JP5318085B2 | Japan | B2 | |
| US8580765B2 | United States of America | B2 | |
| US2014045783A1 | United States of America | A1 | |
| CA2682230C | Canada | C | |
| EP2203462B1 | European Patent Office (EPO) | B1 | |
| US8735372B2 | United States of America | B2 | |
| SG2014011704A | Singapore | A | |
| RU2012152811A | Russian Federation | A | |
| JP5539419B2 | Japan | B2 | |
| US2014187511A1 | United States of America | A1 | |
| DK2203462T3 | Denmark | T3 | |
| KR101432860B1 | Republic of Korea | B1 | |
| PT2203462E | Portugal | E | |
| ES2492470T3 | Spain | T3 | |
| AU2014215983A1 | Australia | A1 | |
| AU2012241173B2 | Australia | B2 | |
| US2014288020A1 | United States of America | A1 | |
| SI2203462T1 | Slovenia | T1 | |
| SI2203462T1 | Slovenia | T1 | |
| HRP20140667T1 | Croatia | T1 | |
| AU2014233579A1 | Australia | A1 | |
| JP2014196305A | Japan | A | |
| EP2792680A1 | European Patent Office (EPO) | A1 | |
| US2014315852A1 | United States of America | A1 | |
| EP2801580A1 | European Patent Office (EPO) | A1 | |
| FIC20140055I1 | Finland | I1 | |
| NO2014029I2 | Norway | I2 | |
| NO2014029I1 | Norway | I1 | |
| US8906880B2 | United States of America | B2 | |
| FR14C0082I1 | France | I1 | |
| EP2824109A1 | European Patent Office (EPO) | A1 | |
| EP2826784A1 | European Patent Office (EPO) | A1 | |
| KR20150008929A | Republic of Korea | A | |
| PL2203462T3 | Poland | T3 | |
| JP2015024998A | Japan | A | |
| US8957046B2 | United States of America | B2 | |
| CN104402955A | China | A | |
| AU2008232827C1 | Australia | C1 | |
| BRPI0809654A2 | Brazil | A2 | |
| KR101525293B1 | Republic of Korea | B1 | |
| KR101527701B1 | Republic of Korea | B1 | |
| US9085573B2 | United States of America | B2 | |
| US2015231166A1 | United States of America | A1 | |
| JP5774749B2 | Japan | B2 | |
| EP2933260A1 | European Patent Office (EPO) | A1 | |
| PH12014502771A1 | Philippines | A1 | |
| BRPI0823519A2 | Brazil | A2 | |
| FR14C0082I2 | France | I2 | |
| LU92600I2 | Luxembourg | I2 | |
| NL300704I1 | Netherlands (Kingdom of the) | I1 | |
| NL300704I2 | Netherlands (Kingdom of the) | I2 | |
| HK1206033A | Hong Kong, China | A | |
| HK1206033A1 | Hong Kong, China | A1 | |
| HK1206034A | Hong Kong, China | A | |
| HK1206034A1 | Hong Kong, China | A1 | |
| JP2016023187A | Japan | A | |
| AU2014233579B2 | Australia | B2 | |
| AU2016213882A1 | Australia | A1 | |
| AU2016231535A1 | Australia | A1 | |
| CY1115488T1 | Cyprus | T1 | |
| US9585906B2 | United States of America | B2 |
4 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 217228
- Publication, DOCDB
- 217228
- Publication, EPODOC
- IL217228
- Application
- 217228
- Application, DOCDB
- 21722811
- Application, EPODOC
- IL20110217228
Titles2
- English
- Nucleoside phosphoramidate prodrugs of 2'-deoxy-2'-fluoro-2'-c-methyluridine
- Hebrew
- תרכובות של נוקליאוסיד פוספוראמידט מסוג 2'–דאוקסי–2'–פלואורו–2'–c–מתילאורידין
Classification
- CPC, 22
- C07H19/10
- A61K31/7064
- A61K31/7072
- C07H19/16
- A61K31/706
- A61K31/7076
- A61K31/7068
- C07D417/14
- A61P31/00
- A61P31/12
- A61P31/14
- A61P31/16
- A61P31/18
- A61P31/20
- A61P43/00
- Y02A50/30
- C07H19/06
- C07H19/20
- C07H19/04
- A61K45/06
- C07H17/02
- C07H19/073
- IPC, 3
- A61K
- A61P
- C07H